Novavax, a leader in vaccine development, announced the FDA’s removal of a clinical hold on their COVID-19-Influenza combination and influenza vaccine trials, paving the way for Phase 3 trials to ...
During a Case-Based Roundtable® event, Lori J. Wirth, discussed the SELECT trial and the role of multikinase inhibitors in ...
Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC) and standalone influenza vaccines. The FDA lifted a clinical hold that ...
Auto parts maker Magna International sees quarterly net income hit US$328 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback